National Research (NASDAQ:NRC) Shares Cross Above Two Hundred Day Moving Average – What’s Next?

National Research Corporation (NASDAQ:NRC) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $18.89 and traded as high as $21.61. National Research shares last traded at $21.19, with a volume of 144,667 shares changing hands.

Wall Street Analyst Weigh In

NRC has been the topic of a number of recent analyst reports. Wall Street Zen downgraded shares of National Research from a “buy” rating to a “hold” rating in a research report on Saturday, August 15th. Weiss Ratings raised National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, August 21st. Finally, Citizens Jmp increased their price target on National Research from $23.00 to $26.00 and gave the stock a “market outperform” rating in a report on Wednesday, July 29th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $26.00.

National Research Stock Performance

The company has a market capitalization of $483.67 million, a price-to-earnings ratio of 85.04 and a beta of 0.35. The company has a 50 day moving average price of $21.25 and a 200 day moving average price of $18.95. The company has a debt-to-equity ratio of 13.13, a quick ratio of 0.65 and a current ratio of 0.65.

National Research (NASDAQ:NRC) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.31 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.46. National Research had a return on equity of 164.26% and a net margin of 4.18%.The business had revenue of $35.39 million for the quarter, compared to the consensus estimate of $34.90 million.

National Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 9th. Stockholders of record on Friday, September 25th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend is Friday, September 25th. National Research’s dividend payout ratio is presently 256.00%.

Institutional Trading of National Research

Hedge funds have recently bought and sold shares of the business. Cubist Systematic Strategies LLC bought a new stake in National Research during the 1st quarter valued at $118,000. AQR Capital Management LLC lifted its stake in shares of National Research by 168.6% in the first quarter. AQR Capital Management LLC now owns 108,134 shares of the company’s stock valued at $1,384,000 after buying an additional 67,882 shares in the last quarter. Jane Street Group LLC lifted its stake in shares of National Research by 394.2% in the first quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock valued at $671,000 after buying an additional 41,806 shares in the last quarter. Strs Ohio bought a new position in shares of National Research in the first quarter valued at $33,000. Finally, M&T Bank Corp grew its holdings in shares of National Research by 6.4% during the second quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock valued at $229,000 after buying an additional 823 shares during the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.